World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
72
Citations
21100
World Ranking
1729
National Ranking
742

Medicine

D-Index
74
Citations
22170
World Ranking
19359
National Ranking
9641

Overview

Francisco M. Marty was affiliated with Brigham and Women's Hospital in the United States. Their research primarily focused on medicine, with a specialization in epidemiology, infectious diseases, oncology, neurology, and transplantation.

Themes of their scientific work included:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • COVID-19 clinical research studies
  • Cytomegalovirus and herpesvirus research
  • Long-term effects of COVID-19
  • SARS-CoV-2 and COVID-19 research
  • Herpesvirus infections and treatments

They published frequently in the following venues:

  • Open Forum Infectious Diseases
  • New England Journal of Medicine
  • Clinical Infectious Diseases
  • Blood Advances
  • Transplantation and Cellular Therapy

Notable recent papers included:

  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19, 2020, New England Journal of Medicine
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19, 2020, JAMA
  • Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients, 2021, New England Journal of Medicine
  • Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial, 2021, Clinical Infectious Diseases
  • How to Obtain a Nasopharyngeal Swab Specimen, 2020, New England Journal of Medicine

Collaborators commonly working with Francisco M. Marty included Matthew P. Cheng, Isabel H Gonzalez-Bocco, Muneerah M Aleissa, Sarah P. Hammond, and Kaiwen Chen.

Best Publications

  • Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

    Unknown

  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

    Jason D. Goldman;David C.B. Lye;David S. Hui;Kristen M. Marks

  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.

    Christoph D. Spinner;Robert L. Gottlieb;Gerard J. Criner;José Ramón Arribas López

  • Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • Transmission of lymphocytic choriomeningitis virus by organ transplantation.

    Staci A. Fischer;Mary Beth Graham;Matthew J. Kuehnert;Camille Nelson Kotton

  • Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants

    Francisco M Marty;Lisa A Cosimi;Lindsey R Baden

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

  • CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

    Francisco M. Marty;Drew J. Winston;Scott D. Rowley;Estil Vance

  • Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

    Francisco M. Marty;Per Ljungman;Genovefa A. Papanicolaou;Drew J. Winston

  • Persistent and relapsing babesiosis in immunocompromised patients.

    Peter J. Krause;Benjamin E. Gewurz;Benjamin E. Gewurz;David Hill;Francisco M. Marty

  • Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

    Unknown

  • Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6

    W. W. Seeley;F. M. Marty;T. M. Holmes;K. Upchurch

  • Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.

    Stanley I. Martin;Francisco M. Marty;Karen Fiumara;Steven P. Treon;Steven P. Treon

  • Diagnostic Performance of the (1→3)-β-d-Glucan Assay for Invasive Fungal Disease

    Sophia Koo;Sophia Koo;Julie M. Bryar;Julie M. Bryar;John H. Page;Lindsey R. Baden;Lindsey R. Baden

  • Three Patients with Full Facial Transplantation

    Bohdan Pomahac;Julian Joseph Pribaz;Elof Eriksson;Ericka Bueno

  • Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

    Francisco M. Marty;Stephanie J. Lee;Michelle M. Fahey;Edwin P. Alyea

  • Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

    Francisco M. Marty;Wendy W. Yeh;Christine B. Wennersten;Lata Venkataraman

  • How to Obtain a Nasopharyngeal Swab Specimen.

    Francisco M Marty;Kaiwen Chen;Kelly A Verrill

  • Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study

    Genovefa A Papanicolaou;Fernanda P Silveira;Amelia A Langston;Marcus R Pereira

  • Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis

    Candace H. Feldman;Linda T. Hiraki;Wolfgang C. Winkelmayer;Francisco M. Marty

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

Frequent Co-Authors

Lindsey R. Baden
Lindsey R. Baden Brigham and Women's Hospital
Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute
Robert J. Soiffer
Robert J. Soiffer Harvard University
Vincent T. Ho
Vincent T. Ho Harvard University
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center
Corey Cutler
Corey Cutler Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
John Koreth
John Koreth Harvard University
Stefan G. Tullius
Stefan G. Tullius Brigham and Women's Hospital
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various related fields and career pathways, many of which can be completed online. For example, healthcare administration roles often benefit from certifications such as the accredited fast medical billing and coding certificate online, which provides specialized skills for efficient healthcare data management.

If you’re interested in expanding your medical knowledge, you may explore options like a what medical degree can i get online to understand the landscape of online medical programs available today. These programs offer flexibility for working professionals and can complement a microbiology background.

Public health is another promising area linked to microbiology, especially with growing global health concerns. Many students choose to pursue an online mph programs easy to get into, allowing them to develop essential skills for disease prevention and health promotion in diverse communities.

Additionally, for those interested in child development and healthcare, obtaining a ccls certification can lead to rewarding careers supporting children in medical settings, integrating knowledge from microbiology with psychosocial care.

Best Scientists Citing Francisco M. Marty